TITLE

Glaxo Next into Pharma Deal Pool?

AUTHOR(S)
Marino, Jonathan
PUB. DATE
March 2009
SOURCE
Mergers & Acquisitions Report;3/30/2009, Vol. 22 Issue 13, p6
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on reports claiming that British pharmaceutical company GlaxoSmithKline is considering acquiring a stake in a generic South African drug maker and California-based firm Allergan. Credit Suisse predicts GlaxoSmithKline would pay 48 U.S. dollars per share to buy Allergan. Glaxo is also expected to acquire up to 20% of the South African pharmaceutical firm.
ACCESSION #
44128034

 

Related Articles

  • New Drugs, Profits Boost Allergen Shares to New Highs. Gondo, Nancy // Orange County Business Journal;11/27/2000, Vol. 23 Issue 48, p1 

    Reports on record highs for the stock price of Irvine, California-based drug maker Allergan Inc. in November 2000. Impact of the firm's strong financial performance; Range of innovative products launched by the firm in the market; Growth targets and strategies.

  • Allergan. Investor's Business Daily // Investors Business Daily;8/11/2014, pA02 

    The article reports on the 3% increase in the shares of Allergan Inc., a maker of Botox, on August 7, 2014 and on the 12% decline on its stock over the prior six trading days.

  • Weekly Stock Performance.  // MondayMorning;6/9/2014, Vol. 22 Issue 21, p1 

    A table is presented which lists the weekly stock performance as of June 6, 2014 of the biopharmaceutical companies including GlaxoSmithKline, Pfizer and Allergan.

  • Perilya attractive.  // BRW;9/18/2008, Vol. 30 Issue 37, p72 

    The article reports that Credit Suisse has an outperform recommendation on the stock of Australian base metal company, Perilya. According to Credit Suisse, Perilya's sale of its Mount Oxide copper project to Chalice for $22 million was disappointing, as it was an all scrip transaction and did...

  • Facebook's. Investor's Business Daily // Investors Business Daily;4/30/2014, pA02 

    The article reports on the decision of global financial services company Credit Suisse Group AG to increase the price target of online social networking service Facebook Inc. from 87 to 90 in 2014.

  • Market Watch.  // Orange County Business Journal;2/10/2014, Vol. 37 Issue 6, p28 

    Several charts and graphs related to stock and revenue of business enterprises in California are presented which includes Allergan Inc., Western Digital Corp. and Microsemi Corp.

  • Valeant Pharmaceuticals. Investor's Business Daily // Investors Business Daily;6/17/2014, pA02 

    The article reports on the financial performance of several pharmaceutical industries such as the 1.6% decrease of shares by Valeant Pharmaceuticals Inc. and the 1.5% decline of share by Allergan Inc.

  • Allergan said to gain 3 patents. Investor's Business Daily // Investors Business Daily;12/23/2013, pA02 

    Shares of the branded prescription and over-the-counter drugmaker shot up a 2nd day in a row on reports that 3 new patent applications

  • Market watch.  // Orange County Business Journal;01/17/2000, Vol. 23 Issue 3, p16 

    Presents charts and graphs reflecting the stock performance of companies in Orange County, California listed under the Cruttenden Roth and Billion-Dollar Club stock indexes recent to January 17, 2000. Includes Allergan Inc.; Fluor Corp.; QLogic Corp.; Closing price; Market capitalization;...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics